Literature DB >> 10873657

Neovascularization with blood-brain barrier breakdown in delayed neuronal death.

Y Kataoka1, Y Cui, H Yamada, K Utsunomiya, H Niiya, H Yanase, Y Nakamura, A Mitani, K Kataoka, Y Watanabe.   

Abstract

Various kinds of acute pathological events in the central nervous system, such as ischemia, hemorrhage, and trauma, often cause brain edema. The edema may advance for days or weeks while inducing extensive damage in neural function, regardless of the extent of the original damage, and often results in death. Delayed edema is thought to be vasogenic; however, the mechanism underlying edema induction remains unknown. We found delayed vascular cell proliferation with a blood-brain barrier breakdown in and around the gerbil CA1 hippocampus, a region known to be involved in delayed apoptotic neuronal death 2-6 days after transient ischemia. Vascular cell proliferation, assessed by (3)H-thymidine incorporation, was most prominent 4-6 days after ischemia, and extravasation of exogenously applied dye or endogenous serum albumin from blood vessels was observed concomitantly. We propose neovascularization in delayed neuronal death as a cause of brain edema advancing days after neurological events. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10873657     DOI: 10.1006/bbrc.2000.2975

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats.

Authors:  Csongor S Abrahám; Noboru Harada; Mária A Deli; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2002-08       Impact factor: 5.046

2.  Transient cerebral ischemia induces albumin expression in microglia only in the CA1 region of the gerbil hippocampus.

Authors:  Joon Ha Park; Jin-A Park; Ji Hyeon Ahn; Yang Hee Kim; Il Jun Kang; Moo-Ho Won; Choong-Hyun Lee
Journal:  Mol Med Rep       Date:  2017-05-31       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.